SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bharat H. Barai who wrote (75)3/2/1997 9:09:00 AM
From: NVestor   of 834
 
1. Any chance that the company might price the product low enough that it would directly compete with heparin since the market is so huge.

2. Might doctors use the product routinely fearing they might be sued sued if the bad reaction to heparin did result when there is another product on the market that does not produce this reaction ?

If either of the above apply, it would seem that the upside for this company would be tremendous since the market would be so vast.
(Perhaps Lehman Bros. target of 16 might be conservative under either of these scenarios.)

Any thoughts on this?
Thanks
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News